These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9310740)

  • 61. Predictive factors for failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients.
    Lehucher-Ceyrac D; de La Salmonière P; Chastang C; Morel P
    Dermatology; 1999; 198(3):278-83. PubMed ID: 10393453
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
    Kaymak Y; Ilter N
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Severe acne infantum successfully treated with isotretinoin.
    Torrelo A; Pastor MA; Zambrano A
    Pediatr Dermatol; 2005; 22(4):357-9. PubMed ID: 16060877
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of isotretinoin on the quality of life of patients with acne.
    Simpson N
    Pharmacoeconomics; 1994 Aug; 6(2):108-13. PubMed ID: 10147436
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Systemic treatment of acne: recommendations. The French Agency of Sanitary Safety of Health Products].
    Ann Dermatol Venereol; 1999 Mar; 126(3):233-4. PubMed ID: 10394435
    [No Abstract]   [Full Text] [Related]  

  • 66. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study: comment.
    Berk DR
    Br J Dermatol; 2011 Jul; 165(1):205. PubMed ID: 21410669
    [No Abstract]   [Full Text] [Related]  

  • 67. Monitoring of isotretinoin therapy by measuring the plasma levels of isotretinoin and 4-oxo-isotretinoin. A useful tool for management of severe acne.
    Almond-Roesler B; Blume-Peytavi U; Bisson S; Krahn M; Rohloff E; Orfanos CE
    Dermatology; 1998; 196(1):176-81. PubMed ID: 9557257
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low-dose isotretinoin in the treatment of acne vulgaris.
    Amichai B; Shemer A; Grunwald MH
    J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management.
    Del Rosso JQ
    J Drugs Dermatol; 2013 Jun; 12(6):626-31. PubMed ID: 23839177
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Systemic treatment of acne: proposal. The French Agency of Sanitary Safety of Health Products].
    Ann Dermatol Venereol; 1999 Mar; 126(3):224-31. PubMed ID: 10394434
    [No Abstract]   [Full Text] [Related]  

  • 71. How to ensure fetal safety when mothers use isotretinoin (Accutane).
    Koren G; Pastuszak A
    Can Fam Physician; 1997 Feb; 43():216-9. PubMed ID: 9040906
    [No Abstract]   [Full Text] [Related]  

  • 72. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
    Boyraz N; Mustak PK
    Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New warnings on the use of isotretinoin (Roaccutane).
    Gunston G; Mehta U; van de Wal B
    S Afr Med J; 1998 Nov; 88(11):1394. PubMed ID: 9861942
    [No Abstract]   [Full Text] [Related]  

  • 74. Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin.
    Quéreux G; Volteau C; N'Guyen JM; Dréno B
    Dermatology; 2006; 212(2):168-76. PubMed ID: 16484824
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission.
    Borghi A; Mantovani L; Minghetti S; Giari S; Virgili A; Bettoli V
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1094-8. PubMed ID: 21198947
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cost-benefit of isotretinoin (Roaccutane).
    Wishart J; Villiger J
    N Z Med J; 1991 May; 104(911):193. PubMed ID: 1827520
    [No Abstract]   [Full Text] [Related]  

  • 77. Safety of performing invasive acne scar treatment and laser hair removal in patients on oral isotretinoin: a retrospective study of 110 patients.
    Chandrashekar BS; Varsha DV; Vasanth V; Jagadish P; Madura C; Rajashekar ML
    Int J Dermatol; 2014 Oct; 53(10):1281-5. PubMed ID: 25039864
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Oral retinoids in the treatment of seborrhoea and acne.
    Orfanos CE; Zouboulis CC
    Dermatology; 1998; 196(1):140-7. PubMed ID: 9557249
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cost of Medications Recommended by Canadian Acne Clinical Practice Guidelines.
    Czilli T; Tan J; Knezevic S; Peters C
    J Cutan Med Surg; 2016 Nov; 20(6):542-545. PubMed ID: 27281440
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Management of severe acne.
    Zouboulis CC; Bettoli V
    Br J Dermatol; 2015 Jul; 172 Suppl 1():27-36. PubMed ID: 25597508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.